From Top 20 Under-the-Radar Trends in Innovation:

Deborah Dunsire (formerly at Millennium)
Deborah Dunsire (formerly at Millennium)

In a word, partnerships! In recent years, pharma pipelines have become increasingly dependent upon biotech partnerships for innovation to help close the pharma industry’s “innovation gap” stemming from increased costs, decreased productivity, and revenue gaps caused by the patent expiry of blockbuster drugs. Now, pharma and biotech are looking towards the academic institutions to forge innovative partnerships for transformation.